Volume 5, Number 3—June 1999
Dispatch
Application of Data Mining to Intensive Care Unit Microbiologic Data1
Table 3
Representative events identified and considered of potential interest
| Partition |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Left Denominator | Right Numerator | 1 | 2 | 3 | 4 | 5 | 6 | 7 | Interpretation | |
| Staphylococcus aureus Source TRACHASPc | ==> | R~Oxacillina, b R~Clindamycin R~Erythromycin | 0/10 | 0/8 | 7/14 | Increase in the incidence of oxacillin (ORSA), clindamycin and erythromycin resistance in all S. aureus isolated from tracheal aspirates. | ||||
| NSNosod | ==> | R~Ceftazidime | 3/88 | 11/70 | Increase in incidence of ceftazidime resistance in all nosocomial isolates. | |||||
| NP_GNRe | ==> | R~Piperacilli | 0/17 | 6/14 | Increase in the LocSICU incidence of piperacillin resistance in non-pseudo-monas gram-negative bacilli isolated from NSNoso. | |||||
| NP_GNR | ==> | R~Piperacillin | 1/12 | 0/14 | 4/11 | 4/8 | Increase in the LocSICUf incidence of piperacillin resistance in non-pseudo-monas, nosocomial gram- negative bacilli from the SICU. | |||
| NSNoso LocNICUg | ==> | S. aureus | 3/26 | 3/26 | 2/28 | 6/27 | 5/20 | 3/11 | Increase in the incidence of nosocomial S. aureus in nosocomial isolates from the NICU. | |
aR, resistant.
bOxacillin, resistance implies resistance to amoxycillin/clavulanic acid, cephalothin, and cefazolin.
cSourceTRACHASP, tracheal aspirates.
dNSNoso, nosocomial (3 days from admission).
eNP_GNR, non-pseudomonas gram-negative rod.
fLocSICU, location, surgical intensive care unit (SICU).
gLocNICU, location, neonatal intensive care unit (NICU).


